Product Information
METHYLPHENIDATE ER(LA) 30 MG CP is a generic product labeled by Sandoz Inc., priced at $2.0321 per EA under NDC 00781236301. Its NADAC has been published 547 times since Jan 6, 2016.
Strength
30 mg/1
Manufacturer
Sandoz Inc.NDC
00781236301
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021284On Market Since
11/24/2015
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has been published 547 times since Jan 6, 2016, and over the history we have for it it has declined 71.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0321 per EA |
|---|---|
| All-time high | $7.1675 (Jan 6, 2016) |
| All-time low | $1.0799 (May 19, 2021) |
| 52-week high | $2.9073 |
| 52-week low | $2.0321 |
| Median price | $2.7724 |
| Average price | $2.8686 |
| Largest weekly change | +71.5% (Aug 23, 2023) |
| Weeks tracked | 547 |
| Tracking since | Jan 6, 2016 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER(LA) 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 30 MG CP, manufactured by Sandoz Inc., is $2.0321 per EA (NDC 00781236301), effective Jun 24, 2026.
How has the price of METHYLPHENIDATE ER(LA) 30 MG CP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has declined 71.6%. It has been tracked across 547 weekly CMS publications since Jan 6, 2016.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 30 MG CP?
Since Jan 6, 2016, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has ranged from a low of $1.0799 (May 19, 2021) to a high of $7.1675 (Jan 6, 2016), with a median of $2.7724 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 30 MG CP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as METHYLPHENIDATE ER(LA) 30 MG CP, but none are currently priced below it.
Who manufactures METHYLPHENIDATE ER(LA) 30 MG CP?
METHYLPHENIDATE ER(LA) 30 MG CP (NDC 00781236301) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification